Our Mission<\/h2>\n
The role of the medical oncologist in the multidisciplinary care of the head and neck cancer patient is overall treatment planning and the use of anti-cancer medicines.<\/p>\n
The majority of patients are treated with a goal of cure. In these cases, systemic therapies (medications that travel throughout the body) such as chemotherapy, targeted therapy, and immunotherapy may be used to shrink cancer prior to surgery or radiation, at the same time as radiation or following surgery or radiation. When cure is not possible, we believe that the purpose of care is to maximize quality of life and duration of life. To this end, we work with patients to individualize treatment plans that minimize side effects and maximize efficacy. Whenever possible, we attempt to use cutting-edge molecular diagnostics, clinical trials, immunotherapy, and targeted therapy to avoid the use of chemotherapy.<\/p>\n
We are proud to offer cutting-edge trials aimed at increasing the rate of cure, decreasing side effects, and offering hope where standard therapies cannot. We heavily vet our clinical trials for scientific promise (likelihood of working), minimization of potential side effects, ethics, and patient convenience. We offer trials using novel immunotherapies, cellular therapy (such as tumor infiltrating lymphocytes (TILs), and CAR-T), targeted therapies, and novel agents (phase I).<\/p>\n
\n
Our Team<\/h2>\n
<\/a><\/p>\n Head and neck cancer requires tight integration of numerous specialists to optimize care. Our team meets every Friday to discuss patients at the UNC Head and Neck Tumor Conference. This conference is attended by clinicians from all related specialties, with a shared passion to reduce suffering from head and neck cancer, \u00a0including ENT surgeons, radiation oncology, head and neck medical oncology, radiology, head and neck pathology, nurse navigators, and clinical trial coordinators.<\/p>\n We believe strongly that this collaborative approach, with everyone reviewing and discussing imaging, pathology and other data together improves care. We have also physically structured our clinics so that we all see patients in the same space.\u00a0 We believe that this improves care by facilitating interdisciplinary discussions.<\/p>\n Nurse Navigator<\/p> <\/div>\n \n \n<\/li> Nurse Navigator<\/p> <\/div>\n \n \n<\/li> <\/ul>\n <\/section>\n <\/nav>\n\n \n Nurse navigators are the heart of our program.\u00a0 Nurse navigators provide a single point of contact for patients and their families, allowing us to bring to bear the powerful resources of a large and advanced program, with the ease of a smaller hospital. Nurse navigators provide supportive care, patient counseling and care coordination.<\/p>\n We have a dedicated head\/neck oncology clinical pharmacist. Our pharmacists are experts in treatment selection, side effects, and monitoring. They assist with patient access to medications, counseling on how to take new treatments, and strategies to decrease side effects related to cancer therapy.<\/p>\n Rapid healing is not possible without adequate nutrition, so we are passionate about optimizing it.<\/p>\n We greatly value all patients, regardless of ability to pay.\u00a0 We are proud to work at UNC because UNC accepts almost any insurance, as well as patients with no insurance (charity care).\u00a0 We recognize that despite charity care, many patients still have significant barriers to optimal care and work closely with social work to help however we can.<\/p>\n Associate Professor of Medicine<\/p> Lung cancer clinical research group (POD) leader<\/p> <\/div>\n \n \n<\/li> Nurse Practitioner<\/p> <\/div>\n \n \n<\/li> Associate Professor of Medicine<\/p> Head\/Neck Cancer clinical research group (POD) leader<\/p> <\/div>\n \n \n<\/li>Nurse Navigators<\/h3>\n
\n
![\"](\"https:\/\/www.med.unc.edu\/medicine\/oncology\/wp-content\/themes\/heelium-white-coat\/images\/default-profile.svg\")
\n <\/div>\n Susan Boulton <\/a>\n <\/div>\n \t\t\t\t\t\t\t\t\t\t\t\t\n <\/div>\n\n \n <\/div>\n Ashley McFadden <\/a>\n <\/div>\n \t\t\t\t\t\t\t\t\t\t\t\t\n <\/div>\n\n Clinical Pharmacists<\/h3>\n
\n
\n <\/div>\n Morgan Gwynn <\/a>\n <\/div>\n \t\t\t\t\t\t\t\t\t\t\t\t\n <\/div>\n\n Nutrition<\/h3>\n
Social Work<\/h3>\n
Medical Oncology Providers<\/h3>\n
\n
![\"](\"https:\/\/www.med.unc.edu\/medicine\/oncology\/wp-content\/uploads\/sites\/1288\/2023\/03\/Screen-Shot-2025-03-20-at-11.53.53-AM.png\")
\n \n <\/div>\n Shetal Patel, MD, PhD <\/a>\n <\/div>\n \t\n <\/div>\n\n ![\"](\"https:\/\/www.med.unc.edu\/medicine\/oncology\/wp-content\/uploads\/sites\/1288\/2022\/02\/Laura-Shepanski-scaled-2-768x1024.jpeg\")
\n \n <\/div>\n Laura Shepanski, ANP <\/a>\n <\/div>\n \t\n <\/div>\n\n ![\"](\"https:\/\/www.med.unc.edu\/medicine\/oncology\/wp-content\/uploads\/sites\/1288\/2022\/02\/Siddharth-Sheth.jpg\")
\n \n <\/div>\n Siddharth Sheth, DO, MPH <\/a>\n <\/div>\n \t\n <\/div>\n\n
![\"](\"https:\/\/www.med.unc.edu\/medicine\/oncology\/wp-content\/uploads\/sites\/1288\/2023\/06\/Trivedi-Headshot_-819x1024.png\")
\n ![\"](\"https:\/\/www.med.unc.edu\/medicine\/oncology\/wp-content\/uploads\/sites\/1288\/2022\/02\/Weiss-Jared-Facutly-Profile-e1575983759888.jpg\")
\n